Member neha
Member-
neha posted an update in the group
2 months agoPharma News 2 months agoIndian Regulators Crack Down: Strict GMP Compliance Required by Year End
As a clinician, the latest move from drug regulators raises both concern and hope. The DCGI has issued a final directive: all pharma manufacturing plants must fully comply with updated Good Manufacturing Practice (GMP) rules by 31 December 2025, or face closure.
Why…
-
akshay posted an update in the group
2 months agoPharma News 2 months agoCDSCO Releases Updated Draft Guidelines for AI-Enabled Medical Device Software
As a physician who increasingly relies on digital health tools, I find India’s latest move hugely significant: the CDSCO has published a draft guidance document for medical-device software (SaMD and SiMD), including AI/ML-based applications.
What this means for us at…
-
akshay posted an update in the group
2 months agoPharma News 2 months agoIndia Expands CDSCO Workforce With 419 New Drug Inspectors
The Health Ministry has officially approved 419 new Drug Inspector posts under CDSCO to strengthen drug-quality surveillance across the country. This is one of the largest regulatory workforce expansions in years.As a doctor, here’s why this matters for all of us in healthcare:
-
Stronger…
-
-
neha posted an update in the group
2 months agoPharma News 2 months agoIndia’s GST Rate on Medical Devices Cut to 5%
The Indian government has reduced the Goods & Services Tax (GST) on a wide range of medical devices to 5% effective from 22 September 2025.
As a physician, this move signals both opportunity and responsibility:
-
Patient affordability improves – With lower tax, devices such as diagnostics kits,…
-
-
akshay posted an update in the group
2 months agoPharma News 2 months agoIndian Drugmaker Glenmark Pharmaceuticals Reports 72% Profit Surge — What It Means for Clinicians
As a physician, I pay attention not only to new medicines but also to how the pharma industry is evolving — because stronger companies often mean better supply, better innovation and improved access for my patients. Glenmark Pharmaceuticals…
-
neha posted an update in the group
2 months agoPharma News 2 months agoNovo Nordisk Cuts Price of Wegovy by Up to 37% in India
The Danish drug-maker has reduced the Indian retail price of its obesity treatment Wegovy (semaglutide) by up to 37%, aiming to broaden access as competition in the weight-loss drug category intensifies.👨⚕️ From a Doctor’s Perspective
-
Patient access improvement: Lowering the price means…
-
-
akshay posted an update in the group
2 months agoPharma News 2 months agoIndia Launches ‘i-Passport’ for MedTech Startups
As a practicing physician, I believe meaningful change in healthcare doesn’t just come from new drugs — it comes from smarter systems too. Recently, the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam introduced the “i-Passport”, a streamlined gateway for med-tech and health-tech…
-
akshay posted an update in the group
2 months agoPharma News 2 months agoWegovy Price Cut of Up to 37% in India
Novo Nordisk has cut the Indian price of its weight-loss drug Wegovy (semaglutide) by up to 37%.
Why this matters:-
Affordability is a major barrier in real-world practice; price reductions can increase adoption and allow more patients access.
-
However, it also raises expectations: if we use the drug…
-
-
Smart Cold-Chain Tech Lands for Clinics — Take on Vaccine Storage Upgrade
As a practising physician, I’m excited by a new development that directly impacts the front-line of patient care: a team from Blackfrog Technologies in Manipal has launched the EMON-25, an intelligent retrofit system that converts regular medical refrigerators into…
-
akshay posted an update in the group
2 months agoPharma News 2 months ago⚠️ Regulation Tightens on Pharma Manufacturing
As a physician, patient safety is always front and centre—and recent regulatory action in India demands our attention. The Central Drugs Standard Control Organisation (CDSCO) has mandated that all pharmaceutical manufacturers must meet international standards by January 1, 2026—following a tragic…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoNew Drug & Device Milestones Highlight Shift to Innovation
Two recent announcements stand out for us in clinical practice:
-
Finerenone (brand name Kerendia) has just received expanded approval in India for treating adult patients with heart‐failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF). This opens up treatment for a…
-
-
akshay posted an update in the group
3 months agoPharma News 3 months agoWhy Pharma and Physicians Must Connect Beyond the Trial
In my practice, the moment a new drug emerges from trials into the real world, everything changes. While randomized controlled trials give us foundational safety and efficacy, it’s real-world evidence (RWE) that reveals how treatments perform in everyday settings—across comorbidities,…
-
neha posted an update in the group
3 months agoPharma News 3 months agoDigital Roundtables: Redefining Pharma-Physician Engagement
In my daily practice, I’ve noticed how quickly the dynamic between pharmaceutical companies and physicians has shifted—and it’s all moving online. These days, digital roundtables are becoming the primary forum for meaningful engagement.
Instead of crowded conference halls and…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoVirtual Meetings: The New Bridge Between Pharma and Physicians
As a doctor, I’ve seen a major transformation in how the pharmaceutical industry connects with healthcare professionals — and it’s all thanks to virtual meetings. What used to be long in-person sessions or conferences has now evolved into focused, efficient digital…
-
neha posted an update in the group
3 months agoPharma News 3 months agoHow Physician Networking Communities Are Reshaping Patient Care
As a practicing doctor, I’ve come to realize that no single clinician can hold all the answers — especially in today’s rapidly evolving medical landscape. That’s where physician networking communities are proving transformative.
Platforms like HealthSocial are not just…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoHow Artificial Intelligence Is Transforming Communication Across Pharma
As a doctor, I’ve always believed that the foundation of good healthcare lies in communication — between clinicians, patients, researchers, and the pharmaceutical industry. Yet, for decades, that communication has often been fragmented and slow. Today, Artificial…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoCollaborative Platforms: The New Prescription for Healthcare Innovation
As a doctor, I’ve witnessed how digital collaboration platforms are transforming the healthcare industry. Platforms like HealthSocial allow doctors, researchers, and pharma professionals to exchange ideas instantly — breaking silos that once slowed progress.
Whether it’s…
-
neha posted an update in the group
3 months agoPharma News 3 months agoSupreme Court Clears Natco’s Generic Risdiplam: A Win for Patients, a Lesson for Pharma
As a doctor, I see this week’s Supreme Court verdict — allowing Natco Pharma to launch its generic version of Risdiplam — as a landmark moment for both patients and the healthcare ecosystem. Risdiplam is a life-changing drug for Spinal Muscular Atrophy…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoCough Syrup Tragedy Exposes Fragility in India’s Drug Safety Oversight
As a clinician deeply invested in both patient safety and pharmaceutical integrity, recent events surrounding contaminated cough syrups in India have shaken me to the core. This isn’t just “another pharma scandal” — it’s a stark warning that regulatory gaps, quality lapses,…
-
akshay posted an update in the group
3 months agoPharma News 3 months agoThe Rise of Indian Pharma Exports: What It Means for Healthcare Professionals
As a doctor, I’ve always viewed India’s pharmaceutical sector with a sense of pride — it’s often called “the pharmacy of the world.” Over the past decade, Indian pharma exports have grown remarkably, supplying affordable and quality medicines to more than 200…
